certolizumab pegol [Certolizumab Pegol]

tematický
48
Termíny

certolizumab pegovaný
Cimzia
kertolizumab pegol

 

CDP 870
CDP870
Cimzia

Perzistentní odkaz   https://www.medvik.cz/link/D000068582
Definice

A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.

DUI
D000068582 MeSH Prohlížeč
CUI
M0507051
Historická pozn.
2016 (2003)
Veřejná pozn.
2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015

Povolená podhesla

AN
analýza
AD
aplikace a dávkování 12
BI
biosyntéza
CH
chemie
HI
dějiny
EC
ekonomika 1
PK
farmakokinetika 2
PD
farmakologie 11
PH
fyziologie
GE
genetika
IM
imunologie
IP
izolace a purifikace
CL
klasifikace
BL
krev
ME
metabolismus 1
UR
moč
CF
mozkomíšní mok
PO
otrava
AE
škodlivé účinky 6
TU
terapeutické užití 21
TO
toxicita
DE
účinky léků
RE
účinky záření
UL
ultrastruktura

D Chemikálie a léčiva
D05 makromolekulární látky 103
D05.750 polymery 1 059
D05.750.741 polyethylenglykoly 401
D05.750.741.125 certolizumab pegol 48
D05.750.741.250 cetomakrogol 2
D05.750.741.485 PEG-DMA hydrogel 25
D05.750.741.575 nonoxynol 4
D05.750.741.610 oktoxynol 8
D05.750.741.630 polidokanol 3
D05.750.741.650 poloxalen
D05.750.741.667 poloxamer 14
D05.750.741.685 polyhydroxyethylmethakrylát 45
D05.750.741.700 polysorbáty 32
D12 aminokyseliny, peptidy a proteiny 16
D12.644 peptidy 1 389
D12.644.541 peptidové fragmenty 369
D12.644.541.500 imunoglobuliny - fragmenty 187
D12.644.541.500.650 imunoglobuliny - Fab fragmenty 65
D12.644.541.500.650.125 abciximab 14
D12.644.541.500.650.250 certolizumab pegol 48
D12.644.541.500.650.500 variabilní oblast imunoglobulinu 36
D12.644.541.500.650.750 tuftsin 5
D12.776 proteiny 2 584
D12.776.124 krevní proteiny 910
D12.776.124.486 imunoproteiny 14
D12.776.124.486.485 imunoglobuliny 1 493
D12.776.124.486.485.114 protilátky 1 816
D12.776.124.486.485.114.224 monoklonální protilátky 4 693
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky 2 935
D12.776.124.486.485.114.224.060.125 abciximab 14
D12.776.124.486.485.114.224.060.250 adalimumab 353
D12.776.124.486.485.114.224.060.313 alemtuzumab 125
D12.776.124.486.485.114.224.060.344 basiliximab 2
D12.776.124.486.485.114.224.060.375 bevacizumab 453
D12.776.124.486.485.114.224.060.438 brentuximab vedotin 44
D12.776.124.486.485.114.224.060.500 certolizumab pegol 48
D12.776.124.486.485.114.224.060.750 cetuximab 186
D12.776.124.486.485.114.224.060.766 daklizumab 6
D12.776.124.486.485.114.224.060.782 denosumab 157
D12.776.124.486.485.114.224.060.790 gemtuzumab 18
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.486.485.114.224.060.798 ipilimumab 267
D12.776.124.486.485.114.224.060.813 natalizumab 158
D12.776.124.486.485.114.224.060.829 nivolumab 459
D12.776.124.486.485.114.224.060.844 omalizumab 114
D12.776.124.486.485.114.224.060.860 palivizumab 13
D12.776.124.486.485.114.224.060.864 panitumumab 62
D12.776.124.486.485.114.224.060.866 ramucirumab 1
D12.776.124.486.485.114.224.060.868 ranibizumab 63
D12.776.124.486.485.114.224.060.875 trastuzumab 278
D12.776.124.486.485.114.224.060.937 ustekinumab 124
D12.776.124.486.485.680 imunoglobuliny - fragmenty 187
D12.776.124.486.485.680.650 imunoglobuliny - Fab fragmenty 65
D12.776.124.486.485.680.650.125 abciximab 14
D12.776.124.486.485.680.650.250 certolizumab pegol 48
D12.776.124.486.485.680.650.500 variabilní oblast imunoglobulinu 36
D12.776.124.486.485.680.650.750 tuftsin 5
D12.776.124.790 sérové globuliny 61
D12.776.124.790.651 imunoglobuliny 1 493
D12.776.124.790.651.114 protilátky 1 816
D12.776.124.790.651.114.224 monoklonální protilátky 4 693
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky 2 935
D12.776.124.790.651.114.224.060.125 abciximab 14
D12.776.124.790.651.114.224.060.250 adalimumab 353
D12.776.124.790.651.114.224.060.375 alemtuzumab 125
D12.776.124.790.651.114.224.060.407 basiliximab 2
D12.776.124.790.651.114.224.060.438 bevacizumab 453
D12.776.124.790.651.114.224.060.469 brentuximab vedotin 44
D12.776.124.790.651.114.224.060.500 certolizumab pegol 48
D12.776.124.790.651.114.224.060.750 cetuximab 186
D12.776.124.790.651.114.224.060.766 daklizumab 6
D12.776.124.790.651.114.224.060.782 denosumab 157
D12.776.124.790.651.114.224.060.790 gemtuzumab 18
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin 12
D12.776.124.790.651.114.224.060.798 ipilimumab 267
D12.776.124.790.651.114.224.060.813 natalizumab 158
D12.776.124.790.651.114.224.060.829 nivolumab 459
D12.776.124.790.651.114.224.060.844 omalizumab 114
D12.776.124.790.651.114.224.060.860 palivizumab 13
D12.776.124.790.651.114.224.060.864 panitumumab 62
D12.776.124.790.651.114.224.060.866 ramucirumab 1
D12.776.124.790.651.114.224.060.868 ranibizumab 63
D12.776.124.790.651.114.224.060.875 trastuzumab 278
D12.776.124.790.651.114.224.060.937 ustekinumab 124
D12.776.124.790.651.680 imunoglobuliny - fragmenty 187
D12.776.124.790.651.680.650 imunoglobuliny - Fab fragmenty 65
D12.776.124.790.651.680.650.125 abciximab 14
D12.776.124.790.651.680.650.250 certolizumab pegol 48
D12.776.124.790.651.680.650.500 variabilní oblast imunoglobulinu 36
D12.776.124.790.651.680.650.750 tuftsin 5
D12.776.377 globuliny 68
D12.776.377.715 sérové globuliny 61
D12.776.377.715.548 imunoglobuliny 1 493
D12.776.377.715.548.114 protilátky 1 816
D12.776.377.715.548.114.224 monoklonální protilátky 4 693
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky 2 935
D12.776.377.715.548.114.224.200.125 abciximab 14
D12.776.377.715.548.114.224.200.250 adalimumab 353
D12.776.377.715.548.114.224.200.375 alemtuzumab 125
D12.776.377.715.548.114.224.200.407 basiliximab 2
D12.776.377.715.548.114.224.200.438 bevacizumab 453
D12.776.377.715.548.114.224.200.469 brentuximab vedotin 44
D12.776.377.715.548.114.224.200.500 certolizumab pegol 48
D12.776.377.715.548.114.224.200.750 cetuximab 186
D12.776.377.715.548.114.224.200.766 daklizumab 6
D12.776.377.715.548.114.224.200.782 denosumab 157
D12.776.377.715.548.114.224.200.790 gemtuzumab 18
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin 12
D12.776.377.715.548.114.224.200.798 ipilimumab 267
D12.776.377.715.548.114.224.200.813 natalizumab 158
D12.776.377.715.548.114.224.200.829 nivolumab 459
D12.776.377.715.548.114.224.200.844 omalizumab 114
D12.776.377.715.548.114.224.200.860 palivizumab 13
D12.776.377.715.548.114.224.200.864 panitumumab 62
D12.776.377.715.548.114.224.200.866 ramucirumab 1
D12.776.377.715.548.114.224.200.868 ranibizumab 63
D12.776.377.715.548.114.224.200.875 trastuzumab 278
D12.776.377.715.548.114.224.200.937 ustekinumab 124
D12.776.377.715.548.680 imunoglobuliny - fragmenty 187
D12.776.377.715.548.680.650 imunoglobuliny - Fab fragmenty 65
D12.776.377.715.548.680.650.125 abciximab 14
D12.776.377.715.548.680.650.250 certolizumab pegol 48
D12.776.377.715.548.680.650.500 variabilní oblast imunoglobulinu 36
D12.776.377.715.548.680.650.750 tuftsin 5

Přidat